{
  "retracted": false,
  "timestamp": 1520899200000,
  "updates": [
    {
      "timestamp": 1592220257087,
      "identifier": {
        "doi": "10.1038/ncomms16187"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/ncomms15987"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target"
}
